Statistics for SGLT2 Inhibitor for Cardiac Protection in a Patient With Osimertinib-Responsive Advanced EGFR-Positive Lung Cancer

Total visits

views
SGLT2 Inhibitor for Cardiac Protection in a Patient With Osimertinib-Responsive Advanced EGFR-Positive Lung Cancer 2

Total visits per month

views
January 2025 2
February 2025 0
March 2025 0
April 2025 0
May 2025 0
June 2025 0
July 2025 0

File Visits

views
Belamkar2024Inhibitor-CCBYNCND.pdf 2